New liver test could better predict outcomes for End-Stage patients
NCT ID NCT01907074
First seen Feb 14, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study aimed to see if a new type of liver function test using a substance called cholate could better assess how well the liver works in people with end-stage liver disease. Researchers enrolled 103 participants, including patients with severe liver scarring and living liver donors. The goal was to improve risk prediction and treatment planning, but the study was terminated early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.